Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3733_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Acknowledgments
- •Section A Introduction to Embolic Agents
- •Section B Coils and Plugs
- •2 Pushable Coils
- •3 Detachable Coils
- •4 Vascular Plugs
- •5 Gelatin Sponge
- •6 Polyvinyl Alcohol Particles
- •7 Spherical Embolic Agents
- •Section C Particulate Agents
- •8 Drug-Eluting Beads
- •Section D Liquid Agents
- •9 Glue
- •10 EVOH/DMSO in Peripheral Application
- •11 Sclerosing Agents
- •Section E Catheters
- •12 Catheters and Catheterization Techniques
- •13 Vascular Malformations
- •14 Intracranial Aneurysms
- •Section B Head and Neck Embolization
- •15 Epistaxis
- •16 Vascular Tumors
- •17 Carotid Blowout Syndrome
- •Section C Thoracic Embolization
- •18 Hemoptysis
- •19 Pulmonary Arteriovenous Fistulas
- •20 Chest Tumors
- •Section D Trauma Embolization
- •22 Thoracoabdominal Trauma
- •23 Pelvic Trauma
- •24 Extremity Trauma
- •25 Spine and Bone Trauma
- •26 Iatrogenic Lesions
- •Section E Peripheral Embolization
- •27 Peripheral Vascular Malformations

embolization).
57,60,73
Early rebleeding in general is due to incomplete embolization or
presence of overlooked collateral vessels. Up to 20% of patients will bleed
again in the first month. Late rebleeding (months or years), on the other hand,
is due to progression or reactivation of the underlying disease and lesion
revascularization by collateral vessels from other bronchial arteries and
systemic arteries of the neighborhood.
The main factors for recurrence are improper technique, partial
embolization, or embolization of side branches involved in the injury but
which are not the origin of the bleeding. Other causes include the use of
absorbable embolic agents, acute vascular pathologic processes, or chronic
diseases such as tuberculosis, aspergillosis, and cancer.
13,74,75
Also, if the
primary disease is not adequately treated, such as in tuberculosis and in
aspergillosis lung infections, it is expected to have a higher recurrence rate of
bleeding.
Chronic or resistant tuberculosis has high rate of recurrence, whereas
acute tuberculosis sensitive to antituberculosis therapy has a favorable
outcome with low rate of rebleeding after embolization.
57,75
Hemoptysis is the most common symptom in aspergilloma; it occurs in
69% to 83% of all patients, and it ranges from mild to life threatening, with a
mortality rate ranging from 2% to 50% and with an early and very high
recurrence rate.
57,76
Patients with lung cancer carry a 10% to 30% risk of developing
hemoptysis and are also at risk of recurrence following embolization.
14,77
It is important to know that hemoptysis is a symptom that can become
fatal in patients suffering from a severe pulmonary disease. Embolization is a
symptomatic treatment of hemoptysis. It is necessary to medically or
surgically resolve the underlying condition, when possible.52 It is therefore
important to identify and embolize all vessels that may be contributing to the
abnormal blood supply, including any nonbronchial systemic or pulmonary
arteries. The underlying pathology should be treated if possible to achieve
long-term hemoptysis control.

POTENTIAL COMPLICATIONS
The most frequent complications of hemoptysis embolization include chest
pain (24% to 91%) and dysphagia (1% to 18%). They are temporary
symptoms due to ischemic phenomena caused by embolization of intercostal
and esophageal branches respectively.
13,21,52
It is known that the bronchial arteries supply not only the bronchial
artery branches but also provide for the vasa vasorum of the aorta, pulmonary
artery wall, esophagus, pleura, and spinal cord.
52
To prevent accidental embolization, we have to work in optimal imaging
conditions (adequate equipment, high dose, zoom, and collimation) to
identify any leakage to an undesired structure and with the adequate materials
for microcatheterization. Every injection should be performed under
fluoroscopic control with a slow, careful, and precise infusion of the mixture
(iodine contrast and embolic agent, choosing an adequate proportion
depending on the contrast concentration and the employed agent).
Subintimal dissection of the aorta or the bronchial artery during
hemoptysis embolization is another frequent minor complication, with a
reported prevalence of 1% to 6.3%. There are usually no symptoms or
problems related to it. This complication can be avoided with the use of soft
tip diagnostic catheters, microcatheters coaxially, and gentle hand
injections
15,21
(Fig. 18.17).

Probably the most feared and serious complication is the embolization
of the anterior spinal artery, which can be caused by transverse myelitis. The
prevalence of spinal cord ischemia after hemoptysis embolization is reported
to be 1.4% to 6.5%. When the anterior medullary artery (Adamkiewicz
artery) is visualized at angiography, embolization should not be performed.
Therefore, good imaging and extensive previous diagnostic angiographies or
scans are essential.
54,78–80
As has been already said, sometimes, the medullary artery cannot be
visualized at the beginning of the embolization because it is very thin and
bronchial flow is dominant. Therefore, embolization should always be
performed meticulously, slowly, and under fluoroscopic guidance to stop on
time and avoid its accidental embolization.
36
Another serious but infrequent complication is the posterior cerebral
circulation stroke because of embolism to the occipital cortex, either via
bronchial artery–pulmonary vein shunt or via collateral vessels between
bronchial and vertebral arteries.
81,82
Other rare complications reported in the literature include aortic and
bronchial necrosis, bronchoesophageal fistula, ischemic colitis, and
pulmonary infarction.
83,84
TIPS AND TRICKS
Tips
• Chest CT angiography previous to embolization shortens the
procedure length because it helps to locate the bleeding.
• It is useful to include the entire thoracic aorta in the angiography to
get the whole picture of bronchial and intercostal arteries and any
other anomalous artery arising from the aorta.
• An adequate equipment and radiographic technique that achieve a
high image quality is essential to visualize medullary and esophageal
arteries.
• Anterior medullary artery can usually be found in the left hemithorax.

• Always use a microcatheter coaxial to the diagnostic catheter.
• Always use spherical particles greater than 300 μm to avoid leakage to
the systemic circulation through shunts.
• Ensure distal embolization.
• Systematically check every bronchial and thoracic systemic artery.
• In case of inflammatory or infectious disease such as tuberculosis, do
not forget to also check the pulmonary circulation due to the
possibility of shunting .
Tricks
• Do not introduce the diagnostic catheter (4-Fr to 5-Fr) into the
bronchial artery to avoid vasospasm.
• If it is not possible to stabilize the microcatheter, try to use a 5-Fr to
6-Fr guiding catheter in the aorta.
• Try to get as distally as possible with the microcatheter gently using a
soft tip 0.014-in microwire.
• Use spherical particles greater than 300 μm, ensure a homogenous
mix, and deliver them slowly. Take your time.
• Perform control checks gently and slowly to avoid particle lavage to
the systemic circulation.
• When a medullary, esophageal, or tracheal artery is visualized, it is
possible to close it proximally with a coil to avoid particle
embolization.
• Once distal embolization is ensured, some authors recommend
proximal coil occlusion. Other authors emphatically advise against it.
SUMMARY
Hemoptysis is a fairly common symptom of a group of respiratory diseases.
Fortunately, only a few are massive and/or life threatening. Massive and
recurrent hemoptysis are those that require invasive treatment. In the
management of hemoptysis, location of the bleeding point is essential.
Multidetector CT and bronchoscopy play an important role before

angiography. Embolization with nonabsorbable particles is the preferred
treatment of massive hemoptysis. Embolization is, in general, a symptomatic
treatment: never forget the treatment of the underlying disease, if possible.
Surgery is reserved for some difficult cases and embolization failures.
REFERENCES
1. Haponik EF, Fein A, Chin R. Managing life-threatening hemoptysis: has
anything really changed? Chest. 2000;118:1431–1435.
2. de Gregorio MA, Medrano J, Laborda A, et al. Hemoptysis workup
before embolization: single-center experience with a 15-year period
follow-up. Tech Vasc Interv Radiol. 2007;10:270–273.
3. Najarian KE, Morris CS. Arterial embolization in the chest. J Thorac
Imaging. 1998;13:93–104.
4. Marshall TJ, Jackson JE. Vascular intervention in the thorax: bronchial
artery embolization for haemoptysis. Eur Radiol. 1997;7:1221–1227.
5. Fernando HC, Stein M, Benfield JR, et al. Role of bronchial artery
embolization in the management of hemoptysis. Arch Surg.
1998;133:862–886.
6. Remy J, Voisin C, Ribet M, et al. Treatment, by embolization, of severe
or repeated hemoptysis associated with systemic hypervascularization
[in French]. Nouv Presse Med. 1973;2:2060–2068.
7. Wholey MH, Chamorro HA, Rao G, et al. Bronchial artery embolization
for massive hemoptysis. JAMA. 1976;236:2501–2504.
8. Remy J, Arnaud A, Fardou H, et al. Treatment of hemoptysis by
embolization of bronchial arteries. Radiology. 1977;122:33–37.
9. Uflacker R, Kaemmerer A, Neves C, et al. Management of massive
hemoptysis by bronchial artery embolization. Radiology. 1983;146:627–
634.
10. Uflacker R, Kaemmerer A, Picon PD, et al. Bronchial artery
embolization in the management of hemoptysis: technical aspects and
long-term results. Radiology. 1985;157:637–644.

11. Keller FS, Rosch J, Loflin TG, et al. Nonbronchial systemic collateral
arteries: significance in percutaneous embolotherapy for hemoptysis.
Radiology. 1987;164:687–692.
12. Hayakawa K, Tanaka F, Torizuka T, et al. Bronchial artery embolization
for hemoptysis: immediate and long-term results. Cardiovasc Intervent
Radiol. 1992;15:154–159.
13. Ramakantan R, Bandekar VG, Gandhi MS, et al. Massive hemoptysis
due to pulmonary tuberculosis: control with bronchial artery
embolization. Radiology. 1996;200:691–694.
14. Mal H, Rullon I, Mellot F, et al. Immediate and long-term results of
bronchial artery embolization for life-threatening hemoptysis. Chest.
1999;115:996–1001.
15. Kato A, Kudo S, Matsumoto K, et al. Bronchial artery embolization for
hemoptysis due to benign diseases: immediate and long-term results.
Cardiovasc Intervent Radiol. 2000;23:351–357.
16. Jean-Baptiste E. Clinical assessment and management of massive
hemoptysis. Crit Care Med. 2000;28:1642–1647.
17. Jougon J, Ballester M, Delcambre F, et al. Massive hemoptysis: what
place for medical and surgical treatment. Eur J Cardiothorac Surg.
2002;22:345–351.
18. de Gracia J, de la Rosa D, Catalán E, et al. Use of endoscopic
fibrinogen-thrombin in the treatment of severe hemoptysis. Respir Med.
2003;97:790–795.
19. Bidwell JL, Pachner RW. Hemoptysis: diagnosis and management. Am
Fam Physician. 2005;72:1253–1260.
20. Salajka F. Causes of massive hemoptysis. Monaldi Arch Chest Dis.
2001;56:390–393.
21. Yoon W, Kim JK, Kim YH, et al. Bronchial and nonbronchial systemic
artery embolization for life-threatening hemoptysis: a comprehensive
review. Radiographics. 2001;22:1395–1409.
22. Adelman M, Haponik EF, Bleecker ER, et al. Cryptogenic hemoptisis:
clinical features, bronchoscopic findings, and natural history in 67
patients. Ann Intern Med. 1985;102(6):829–834.

23. de Gregorio MA, Medrano J, Mainar A, et al. Endovascular treatment of
massive hemoptysis by bronchial artery embolization: short-term and
long-term follow-up over a 15-year period. Arch Bronconeumol.
2006;42(2):49–56.
24. Deffenbach ME, Charan NB, Lakshminarayan S, et al. The bronchial
circulation: small, but a vital attribute to the lung. Am Rev Respir Dis.
1987;135:463–481.
25. Furuse M, Saito K, Kunieda E, et al. Bronchial arteries: CT
demonstration with arteriographic correlation. Radiology.
1987;162:393–398.
26. Remy J, Remy-Jardin M, Voisin C. Endovascular management of
bronchial bleeding. In: Butler J, ed. The Bronchial Circulation. New
York, NY: Dekker; 1992:667–723.
27. MacIntosh EL, Parrott JC, Unruh HW. Fistulas between the aorta and
tracheobronchial tree. Ann Thorac Surg. 1991;51:515–519.
28. Hakanson E, Konstantinov IE, Fransson SG, et al. Management of lifethreatening haemoptysis. Br J Anaesth. 2002;88:291–295.
29. Pearse EO, Bryan AJ. Massive haemoptysis 27 years after surgery for
coarctation of the aorta. J R Soc Med. 2001;94:640–641.
30. Bruzzi JF, Rémy-Jardin M, Delhaye D, et al. Multi-detector row CT of
hemoptysis. Radiographics. 2006;26:3–22.
31. Sancho C, Escalante E, Dominguez J, et al. Embolization of bronchial
arteries of anomalous origin. Cardiovasc Intervent Radiol. 1998;21:300–
304.
32. Morita Y, Takase K, Ichikawa H, et al. Bronchial artery anatomy:
preoperative 3D simulation with multidetector CT. Radiology.
2010;255:934–943.
33. Remy-Jardin M, Bouaziz N, Dumont P, et al. Bronchial and
nonbronchial systemic arteries at multi-detector row CT angiography:
comparison with conventional angiography. Radiology. 2004;233:741–
749.
34. Cauldwell EW, Siekert RG, Lininger RE, et al. The bronchial arteries:
an anatomic study of 105 human cadavers. Surg Gynecol Obstet.

1948;86:395–412.
35. Rosenthal D. Spinal cord ischemia after abdominal aortic operation: is it
preventable? J Vasc Surg. 1999;30:391–399.
36. Brown AC, Ray CHE. Anterior spinal cord infarction following
bronchial artery embolization. Semin Intervent Radiol. 2012;29:241–
244.
37. Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive
Care Med. 2003; 29:317–320.
38. Revel MP, Fournier LS, Hennebicque AS, et al. Replace bronchoscopy
in the detection of the site and cause of bleeding in patients with large or
massive hemoptysis? AJR Am J Roentgenol. 2002;179(5):1217–1224.
39. Cahill BC, Ingbar DH. Massive hemoptysis: assessment and
management. Clin Chest Med. 1994;15:147–167.
40. Dweik RA, Stoller JK. Role of bronchoscopy in massive hemoptysis.
Clin Chest Med. 1999;20: 89–105.
41. Hsiao EI, Kirsch CM, Kagawa FT, et al. Utility of fiberoptic
bronchoscopy before bronchial artery embolization for massive
hemoptysis. AJR Am J Roentgenol. 2001;177:861–867.
42. Ponnuswamy I, Sankaravadivelu ST, Maduraimuthu P, et al. 64-detector
row CT evaluation of bronchial and non-bronchial systemic arteries in
life-threatening haemoptysis. Br J Radiol. 2012;85:666–672.
43. Sidhu M, Wieseler K, Burdick TR, et al. Bronchial artery embolization
for hemoptysis. Semin Intervent Radiol. 2008;25:310–318.
44. Hayes D Jr, Winkler MA, Kirkby S, et al. Preprocedural planning with
prospectively triggered multidetector row CT angiography prior to
bronchial artery embolization in cystic fibrosis patients with massive
hemoptysis. Lung. 2012;190:221–225.
45. Hartmann IJ, Remy-Jardin M, Menchini L, et al. Ectopic origin of
bronchial arteries: assessment with multidetector helical CT
angiography. Eur Radiol. 2007;17:1943–1953.
46. Sbano H, Mitchell AW, Ind PW, et al. Peripheral pulmonary artery
pseudoaneurysms and massive hemoptysis. AJR Am J Roentgenol.
2005;184:1253–1259.

47. Chun HJ, Byun JY, Yoo SS, et al. Added benefit of thoracic aortography
after transarterial embolization in patients with hemoptysis. AJR Am J
Roentgenol. 2003;180:1577–1581.
48. Vujic I, Pyle R, Parker E, et al. Control of massive hemoptysis by
embolization of intercostals arteries. Radiology. 1980;137:617–620.
49. Moore LB, McWey RE, Vujic I. Massive hemoptysis: control by
embolization of the thyrocervical trunk. Radiology. 1986;161:173–174.
50. Jardin M, Remy J. Control of hemoptysis: systemic angiography and
anastomoses of the internal mammary artery. Radiology. 1988;168:377–
383.
51. Gwon DI, Ko GY, Yoon HK, et al. Inferior phrenic artery: anatomy,
variations, pathologic conditions, and interventional management.
Radiographics. 2007;27:687–705.
52. Chun JY, Morgan R, Belli AM. Radiological management of
hemoptysis: a comprehensive review of diagnostic imaging and
bronchial arterial embolization. Cardiovasc Intervent Radiol.
2010;33:240–250.
53. Phillips S, Ruttley MS. Bronchial artery embolization: the importance of
preliminary thoracic angiography. Clin Radiol. 2000;55:317–319.
54. Tanaka N, Yamakado K, Murashima S, et al. Superselective bronchial
artery embolization for hemoptysis with a coaxial microcatheter system.
J Vasc Interv Radiol. 1997;8:65–70.
55. White RI Jr. Bronchial artery embolotherapy for control of acute
hemoptysis: analysis of outcome. Chest. 1999;115:912–915.
56. McDonald DM. Angiogenesis and remodeling of airway vasculature in
chronic inflammation. Am J Respir Crit Care Med. 2001;164:S39–S45.
57. Chun JY, Belli AM. Immediate and long-term outcomes of bronchial
and non-bronchial systemic artery embolisation for the management of
haemoptysis. Eur Radiol. 2010;20:558–565.
58. Pump K. Distribution of bronchial arteries in human lung. Chest.
1972;62:447–451.
59. Bernard S, Luchtel D, Polissar N, et al. Structure and size of
bronchopulmonary anastomoses in sheep lung. Anat Rec A Discov Mol

Cell Evol Biol. 2005;286:804–813.
60. Sopko DR, Smith TP. Bronchial artery embolization for hemoptysis.
Semin Intervent Radiol. 2011;28:48–62.
61. Rabkin JE, Astafjev VI, Gothman LN, et al. Transcatheter embolization
in the management of pulmonary hemorrhage. Radiology.
1987;163:361–365.
62. Katoh O, Kishikawa T, Yamada H, et al. Recurrent bleeding after
arterial embolization in patients with hemoptysis. Chest. 1990;97:541–
546.
63. Poyanli A, Acunas B, Rozanes I, et al. Endovascular therapy in the
management of moderate and massive haemoptysis. Br J Radiol.
2007;80:331–336.
64. Corr PD. Bronchial artery embolization for life-threatening hemoptysis
using tris-acryl microspheres: short-term result. Cardiovasc Intervent
Radiol. 2005;28:439–441.
65. Loffroy R, Favelier S, Genson PY, et al. Onyx for embolization of lifethreatening hemoptysis: a promising but luxury embolic agent.
Cardiovasc Intervent Radiol. 2012;35(1):221.
66. Pugnale M, Portier F, Lamarre A, et al. Hemomediastinum caused by
rupture of a bronchial artery aneurysm: successful treatment by
embolization with N-butyl-2 cyanoacrylate. J Vasc Interv Radiol.
2001;12:1351–1352.
67. Baltacioğlu F, Cimşit NC, Bostanci K, et al. Transarterial microcatheter
glue embolization of the bronchial artery for life-threatening
hemoptysis: technical and clinical results. Eur J Radiol. 2010;73:380–
384.
68. Nistri M, Acquafresca M, Pratesi A, et al. Bronchial artery embolization
with detachable coils for the treatment of haemoptysis. Preliminary
experience. Radiol Med. 2008;113:452–460.
69. Schmidt B, Liebers U, Kröncke T, et al. Bronchial artery embolisation
using platinum coils in 52 patients with severe pulmonary hemorrhage
[in German]. Dtsch Med Wochenschr. 2005;130:440–443.
70. Gimeno MJ, Madariaga B, Alfonso ER, et al. Life-threatening
Соседние файлы в папке Библиотека им академика М.И. Перельмана
